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Abstract 
Purpose: To evaluate the anti-inflammatory activity of Liquidambar formosana Hance infructescence 
(Liquidambaris fructus, ELF) in vivo, and clarify its underlying mechanisms. 
Methods: The in vivo anti-inflammatory activity of ELF was examined by xylene-induced ear swelling 
test in mice as well as carrageenan-induced paw edema method in rats. The levels of inflammatory 
cytokines (TNF-α, IL-1β, IL-6 and IL-10) in serum were measured by enzyme-linked immunosorbent 
assay (ELISA), while the expressions of COX-2, iNOS and NF-κB p65 in paw tissue of rats were 
evaluated by western blot. 
Results: After ELF treatment, the levels of TNF-α (p < 0.001), IL-1β (p < 0.001) and IL-6 (p < 0.001) in 
serum decreased and the levels of anti-inflammatory cytokine IL-10 increased (p < 0.01). In addition, 
ELF treatment resulted in decrease of COX-2 (p < 0.01), iNOS (p < 0.01) and NF-κB p65 (p < 0.01) 
expressions in Wistar rats. 
Conclusion: The results reveal that ELF possesses significant anti-inflammatory effect in vivo. The 
anti-inflammatory activity is associated with the levels of TNF-α, IL-1β, IL-6 and IL-10 in serum. 
Furthermore, the suppression of NF-κB p65, iNOS and COX-2 is linked to its anti-inflammatory effect. 
These results provide a rationale for the use of Liquidambaris fructus in inflammatory disease in 
traditional medicine. 
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As is well-known that inflammation is part of the 
complex biological response of body tissues to 
harmful stimuli. The function of inflammation is to 
eliminate invading pathogens and to initiate 
healing process, but while it is uncontrolled, over 
production of inflammatory mediators can lead to 
cellular injury and may even result in several 
diseases [1, 2]. During inflammatory process, 
inflammatory mediators such as NO, PGE2, 
TNF-α, IL-1β, IL-6 and COX-2 are highly 
produced, all of which have been implicated in 
the pathogenesis of tissue injury [3].  
 
Non-steroidal anti-inflammatory drugs (NSAIDs) 
are usually used for the treatment of 
inflammatory diseases. However, numerous side 
effects, such as gastrointestinal disorders, 
immunodeficiency and nephrotoxicity limited the 
wide use of these drugs [4]. Traditional Chinese 
medicine may be another choice for the 
treatment of inflammatory diseases. 
 
Liquidambar formosana Hance belongs to the 
family Hamamelidaceae. The infructescence of 
Liquidambar formosana Hance, named 
Liquidambaris fructus (Lulutong in Chinese), has 
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long been used to treat rheumatism and 
inflammatory diseases in traditional Chinese 
medicine [5]. But so far, few reports on the anti-
inflammatory activities of Liquidambaris fructus 
have been published.  
 
In our study, we administered ELF in vivo and 
found that ELF has anti-inflammatory effect. This 
study may contribute to find the pharmacological 
basis of the use of Liquidambaris fructus in 
traditional Chinese medicine to treat rheumatism 






Male Balb/c mice (18 ~ 22 g weight) and Wistar 
rats (180 ~ 220 g weight) were purchased from 
the Center for Disease Prevention and Control in 
Hubei province, China (no. SCXK (Hubei) 2008-
0005). Animals were housed in plastic cages, 
maintained at 22 ± 2 oC and 45 ~ 65 % humidity 
with alternating 12 h light-dark cycle and given 
free access to both food (standard rat chow) and 
water. They were bred for 1 week to adapt to the 
environment before the experiments.  
 
All experiments were approved by the Committee 
on the Ethics of Animal Experiments of Wuhan 
First Hospital (no. WHYY14021) and followed the 
guidelines of ‘Principles of Laboratory Animal 
Care’ (World Health Organization (WHO) 




The infructescence of Liquidambar formosana 
Hance was purchased from Hubei Tianji Chinese 
Herbal Medicine Co., Ltd (China), authenticated 
by Prof Changgong Zhang (Tongji Medical 
College, Huazhong University of Science and 
Technology, Wuhan, China) according to 
Chinese Pharmacopoeia [5]. A voucher 
specimen (no. L. f 2013-0621) have been 
deposited in Department of Pharmacy, Wuhan 




Carrageenan and indomethacin were purchased 
from Sigma Chemical Co. (USA). TNF-α, IL-1β, 
IL-6, IL-10 ELISA kits were purchased from 
Neobioscience Technology Company (China). 
Antibodies of COX-2, iNOS and NF-κB p65 were 
purchased from Boster Biotechnology Co., Ltd 
(China) and Beijing Bionsynthesis Biotechnology 
Co., Ltd (China) respectively. All other chemicals 
were of analytical grade and purchased locally. 
 
Preparation of the ELF 
 
The air dried Liquidambaris fructus were 
shattered to a fine powder (2.5 kg) and extracted 
with 95 % ethanol (1: 3 w/v) for 1 week at room 
temperature three times. The filtrates were 
combined and concentrated under vacuum at 40 
oC to afford 57.0 g of crude extract, which was 
then suspended in 2 L water and successively 
partitioned with ethyl acetate 3 times (2 L each). 
The ethyl acetate phase was dried under vacuum 
to yield dried powder (32.3 g). The dried powder 
was stored in a refrigerator at 4 oC. 
 
Acute toxicity test 
 
In the acute toxicity study of ELF, Balb/c mice 
were randomly divided into five groups (n = 6): 
the control group, the 0.250 g/kg ELF group, the 
0.500 g/kg ELF group, the 1.000 g/kg ELF group 
and the 2.000 g/kg ELF group. The control group 
received normal saline orally. The rest groups 
were treated with 0.250, 0.500, 1.000 and 2.000 
g/kg ELF by oral route. Mortality, general 
behavioral changes, neurological, signs of 
toxicity and hazardous symptoms of the mice 
were observed continuously for a period of 14 
days [7]. 
 
Xylene-induced mice ear swelling 
 
Xylene-induced mouse ear swelling test is a 
commonly used method to evaluate acute 
inflammation [8]. The mice were randomly 
divided into five groups (n = 8) and treated orally 
with distilled water (10 mL/kg), ELF (75, 150 and 
300 mg/kg) or indomethacin (10 mg/kg) 
respectively 30 minutes before induction of 
swelling by application of xylene (0.02 mL) to the 
inner surface of the left ear. 30 minutes later, the 
animals were sacrificed by cervical dislocation. 
Round pieces (diameter of 8 mm) of both ears of 
the mice were cut off and their weights were 
measured. Quality difference between the left 
and right ear of each animal was calculated and 
inhibition ratio (H) was calculated as in Eq 1 [9]. 
 
H (%) = {(Vc-Vt/Vc)}100…………………… (1) 
 
where Vc represents the weight difference 
between right and left ear in control groups and 
Vt represents the weight difference between right 
and left ear in indomethacin or ELF treated 
groups. 
 
Carrageenan-induced rat paw edema assay 
 
The in vivo anti-inflammatory activity of ELF was 
evaluated by the carrageenan-induced paw 
edema test in male Wistar rats (180 ~ 220 g). 
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The animals were randomly divided into six 
groups (n = 8). Edema was induced by injection 
of 100 μL carrageenan (0.1 % in sterile saline) 
into the sub-plantar tissue of the right hind paw 
while the control group received the same 
volume of saline [10]. 60 minutes before 
carrageenan injection, the animals were treated 
with indomethacin (10 mg/kg), ELF (50, 100 and 
200 mg/kg) or normal amount of saline by oral 
route. Paw thickness was measured at 0, 1, 2, 3, 
4, 5 hours after carrageenan injection using a 
caliper ruler and inhibition ratio was calculated as 
in Eq 2. Then the rats were sacrificed after 
narcotized, and the blood were collected via 
cardiac puncture. The serum was obtained after 
centrifuged at 5000 rpm for 5 min and then 
stored at - 20 oC for TNF-a, IL-6, IL-1β and IL-10 
assay. The carrageenan induced paws were 
dissected, followed by stored at - 80 oC. Then the 
tissue lysate was prepared in RIPA for the 
western blot analysis of COX-2, iNOS, NF-κB 
p65. The tissues were also fixed in 10 % buffered 
formalin for histological assessment. 
 
Inhibition (%) = {(Vc-Vt/Vc)}100 ………… (2) 
 
where Vc represents mean edema volume in the 
control group and Vt represents mean edema 
volume in groups treated with indomethacin or 
ELF. 
 
Measurement of serum TNF-a, IL-6, IL-1β and 
IL-10 by ELISA 
 
The levels of TNF-a, IL-6, IL-1β and IL-10 in 
serum were measured by ELISA kits according 




The paw tissues were fixed in 10 % buffered 
formalin，dehydrated in a gradient ethanol series 
(70 ~ 100 %), and then embedded in paraffin. 
Thereafter, tissues were cut into 5 μm sections, 
and then mounted on clean glass slides and 
dried overnight at 37 oC. Sections were cleared, 
hydrated, and stained with haematoxylin and 
eosin (HE) according to the manufacturers’ 
instructions. Then the histopathological changes 
in all tissue sections were examined with an 
inverted biological microscope (XSP-18CE, 
Changfang, China). 
 
Western blot analysis of COX-2, iNOS and NF-
κB p65 
 
The paw tissues were homogenized in PBS 
buffer (pH = 7.2) and centrifuged at 5000 rpm for 
5 min to obtain supernatant (stored at - 20 ℃). 
Total protein was extracted with a RIPA solution 
(radio immunoprecipitation assay buffer) at - 
20 ℃ overnight. Protein from the supernatant 
was resolved by 12 % SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). Then, the protein 
was transferred onto polyvinylidenefluoride 
membranes. After blocked with 5 % non-fat dried 
milk-TBST buffer (10 mM Tris-HCl, pH 7.4, 100 
mM NaCl and 1 % (v/v) Tween 20), the 
membranes were incubated with primary 
antibodies overnight at 4 oC. Then the 
membranes were washed three times with TBST 
buffer at room temperature. After washing, the 
membranes were incubated with a 1: 2000 
dilution of horseradish peroxidase conjugated 
anti-mouse IgG secondary antibody for 1 h at 
room temperature. After washing three times, the 
membranes were used for protein detection by 
enhanced chemiluminescent assay. The results 
were quantified by Molecular Imaging Software 





All data are expressed as mean ± SEM. 
Statistical significance was assessed by one-way 
analysis of variance (ANOVA), followed by 
Dunnet’s t-test or Student-Newman-Kauls test. P 
< 0.05 was considered statistically significant. 
The analysis was performed using SPSS 




Acute toxicity of ELF 
 
None of the mice showed mortality or overt signs 
of toxicity after 14 days’ treatment. The results 
suggest that ELF has a low toxicity profile. 
 
Effects of ELF on Xylene-induced ear 
swelling 
 
Ear swelling was obvious at 30 min after wipe of 
xylene. The data described in Table 1 showed 
that ELF suppressed xylene-induced ear swelling 
in mice with inhibition rate of 60.67 % and 63.56 
% at the doses of 150 and 300 mg/kg 
respectively. Indomethacin (10 mg/kg) also 
showed significant inhibitory effect. 
 
Effect of ELF on carrageenan-induced rats 
paw edema 
 
The inflammatory response of carrageenan-
induced paw edema test was quantified by 
increment in paw thickness 0, 1, 2, 3, 4 and 5 h 
after carrageenan injection. ELF exhibited a 
dose-dependent suppression of carrageenan-
induced paw edema. The most obvious inhibition 
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activity was exhibited at doses of 200 mg/kg 
(Figure 1) with the inhibition rate of 50.8 % while 
the inhibition rate of indomethacin was 56.4 %. 
 









Control 1% CMC-Na 6.23 ± 0.63  
ELF 
75 4.02 ± 0.52* 35.47 
150 3.53 ± 0.47** 43.34 
300 2.45 ± 0.39*** 60.67 
Indo 10 2.27 ± 0.40*** 63.56 
Data are presented as mean ± SEM (n = 8). *p < 0.05, 
**p < 0.01, ***p < 0.001, compared with the control 
group 
 
Effect of ELF on serum levels of TNF-a, IL-6, 
IL-1β and IL-10 
 
Pro-inflammatory cytokines TNF-a, IL-6, IL-1β 
and anti-inflammatory cytokine IL-10 have central 
roles in the process of inflammation. Therefore, 
levels of TNF-a, IL-6, IL-1β and IL-10 in serum 
after treatment with ELF were detected by 
ELISA. As shown in Figure 2, the levels of TNF-
a, IL-6, IL-1β in serum were decreased while the 
level of IL-10 was increased after ELF treatment 
in a dose-dependent manner. The results 
suggested that obvious inflammation response 
was induced in the model group (carrageenan 
treated group) and ELF could regulate the 
release of inflammatory mediators and therefor 
relieve the inflammatory response in 
carrageenan-induced rats. 
 
Effect of ELF on histopathological changes  
 
Immune cellular infiltration was obviously 
observed in the paw tissue in the model group. 
On the contrary, rats treated with ELF and 
indomethacin showed a reduction in 
inflammatory responses and slightly 
inflammatory cell infiltration (Figure 3), which 
demonstrated that administration of ELF directly 
reduce the inflammation in disease. 
 
Effect of ELF on COX-2, iNOS and NF-κB p65 
expressions in paw tissue 
 
The expression levels of iNOS, COX-2 and NF-
κB p65 in the paw tissue of carrageenan-induced 
rats were measured by western blot analysis. 
The results (Figure 4) showed that expressions 
of COX-2 and NF-κB p65 in the model group 
were significantly increased compared to the 
control group, while the expression levels in ELF 
groups decreased with a dose-dependent 
manner compared to the model group. 
Meanwhile, the expression level of iNOS was 
increased in the model group, and ELF could 




Many plants used in traditional Chinese medicine 
exhibit different pharmacological properties, thus 
they may offer potential as therapeutic agents. 
However, lack of scientific evidence of their 
mechanism of action limited the wide use of 
traditional Chinese medicines. The 
infructescence of Liquidambar formosana Hance 
recorded in Chinese pharmacopoeia, has been 
used for the treatment of various diseases such 
as rheumatism and inflammatory diseases [5]. 
 
Thus, in the present study we administrated ELF 
in vivo, and testify their potential anti-
inflammatory activity by xylene-induced ear 
swelling test and carrageenan induced rat paw 
edema method. The results suggested that ELF 
can significantly suppress the formation of 
xylene-induced ear swelling.  
 
 
Figure 1: Effect of ELF and indomethacin on carrageenan-induced paw edema in rats. (A) change of paw 
edema; (B) edema inhibition rate. Data are presented as mean ± SEM (n = 8). *p < 0.05, **p < 0.01.○: model 
group, ■: indomethacin group, △: 50 mg/kg ELF group, ▼: 100 mg/kg ELF group, ◇: 200 mg/kg ELF group 
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Figure 2: Effect of ELF on TNF-α (A), IL-6 (B), IL-1β (C) and IL-10 (D) production in serum of carrageenan-
induced rats. The animals were treated with different concentrations (50, 100, 200 mg/kg) of ELF followed by 
stimulation with 100 μL carrageenan (0.1 % in saline). The values are presented as mean ± SEM (n = 8); ##p < 




Figure 3: Histological appearance of the paws 5 h after injection of carrageenan (100 ×). Heavy infiltration of 
inflammatory cells can be observed. (A): control group, (B): model group, (C): 50 mg/kg ELF group, (D): 100 
mg/kg ELF group, (E): 200 mg/kg ELF group, (F): 10 mg/kg indomethacin group 
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Figure 4: Effect of ELF on the expressions of iNOS, COX-2 and NF-κB p65 in carrageenan-induced paw tissue. 
The values are presented as means ± SEM (n = 8); ## p < 0.001 compared with the control group; *p < 0.05, 
**p < 0.01 compared with the model group 
 
The inhibition effect of 300 mg/kg ELF was 
comparable to that of 10 mg/kg indomethacin. In 
the carrageenan-induced paw edema 
experiment, ELF at doses of 100 and 200 mg/kg 
showed a long-lasting effect of inhibition of 
swelling during 5 hours. The immune cell 
infiltration was significantly reduced in the paw 
tissue of the mice treated with ELF. The results 
indicated that ELF exhibited significant anti-
inflammatory activity. The anti-inflammatory 
activity is possibly associated with the changes 
of multiple inflammatory chemical mediators 
[11,12]. 
 
A complex cytokine network is involved in 
inflammation process, and this network is 
comprised of positive and negative feedback 
loops that enhance or suppress the inflammatory 
response [13]. During the process of 
inflammation, the release of large amounts of the 
pro-inflammatory cytokines, such as IL-1β, IL-6 
and TNF-α, could lead to the aggravation of 
inflammatory diseases [14, 15]. On the contrary, 
anti-inflammatory cytokines such as IL-10 have 
been shown to inhibit expressions of pro-
inflammatory cytokines [16]. Previous reports 
have demonstrated that IL-10 could suppress the 
inflammatory cytokines IL-1, TNF-α, IL- 6, IL-8, 
and IL-12, as well as inhibit the synthesis of nitric 
oxide, gelatinase, and collagenase [17]. 
Therefore, increased IL-10 and inhibition of pro-
inflammatory cytokines have been proposed to 
be a useful approach to treat inflammatory 
diseases [18]. In the present study, the anti-
inflammatory effect of ELF in the carrageenan-
induced paw edema experiment appears to 
result from the regulation of key cytokines in 
inflammatory pathogenesis, such as decreasing 
the levels of TNF-α, IL-6, IL-1β and increasing 
the level of IL-10 in serum. 
 
NF-κB is a critical factor for the expression of 
various pro-inflammatory cytokines, such as 
TNF-α, IL-6 and IL-1β [19]. Suppression of NF-
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κB can lead to the reduction of pro-inflammatory 
cytokines, thus modulate the inflammatory 
process. Inflammation mediator NO is produced 
by iNOS and involved in many biological 
functions. Overexpression of iNOS is associated 
with inflammatory responses and serious 
disorders such as septic shock and rheumatoid 
arthritis [20]. Our study showed that the levels of 
COX-2, iNOS and NF-κB p65 expressions were 
significantly decreased in ELF and indomethacin 
treated groups. Moreover, the expressions of NF-





The findings indiate that ELF exhibits anti-
inflammatory activity in xylene-induced mice ear 
swelling test and carrageenan-induced rat paw 
edema experiment, and ELF can regulate the 
levels of TNF-α, IL-1β, IL-6 and IL-10 in serum of 
carrageenan treated rats. The anti-inflammatory 
effect is associated with suppression of NF-κB 
p65, iNOS and COX-2. These results may 
suggest that ELF may be useful in the treatment 
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